Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Taking medication for hair loss might cause sexual problems.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Some blood pressure medications are linked to a higher risk of skin cancer.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.